Pages that link to "Q34186477"
Jump to navigation
Jump to search
The following pages link to Rationale for pertussis booster vaccination throughout life in Europe. (Q34186477):
Displaying 50 items.
- The pertussis enigma: reconciling epidemiology, immunology and evolution (Q26772095) (← links)
- Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience (Q26822908) (← links)
- Pertussis: Microbiology, Disease, Treatment, and Prevention (Q30251684) (← links)
- Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools (Q33696832) (← links)
- c-di-GMP enhances protective innate immunity in a murine model of pertussis (Q34343647) (← links)
- Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand (Q34345687) (← links)
- Vaccine-preventable diseases in Europe: where do we stand? (Q34426206) (← links)
- Seroprevalence of pertussis in Senegal: a prospective study (Q34465419) (← links)
- The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study (Q34560049) (← links)
- Pertussis re-emergence in the post-vaccination era (Q34636630) (← links)
- The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young (Q35022663) (← links)
- Combating pertussis resurgence: One booster vaccination schedule does not fit all (Q35062572) (← links)
- Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan (Q35068485) (← links)
- Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. (Q35193398) (← links)
- Vaccination recommendations for Germany (Q35591138) (← links)
- The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010. (Q35846238) (← links)
- Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013. (Q36039358) (← links)
- Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care (Q36092616) (← links)
- Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity. (Q36147897) (← links)
- Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study (Q36334529) (← links)
- T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children (Q36378601) (← links)
- Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century (Q36391852) (← links)
- Whooping cough dynamics in Chile (1932-2010): disease temporal fluctuations across a north-south gradient. (Q36416536) (← links)
- Self-boosting vaccines and their implications for herd immunity (Q36471228) (← links)
- New insights into rotavirus vaccines. (Q36552854) (← links)
- Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. (Q36558999) (← links)
- The resurgence of mumps and pertussis (Q37130711) (← links)
- Issues in pediatric vaccine-preventable diseases in low- to middle-income countries (Q37264972) (← links)
- Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage (Q37342230) (← links)
- Estimated incidence of pertussis in people aged <50 years in the United States (Q37375965) (← links)
- Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan (Q37469300) (← links)
- Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. (Q37545038) (← links)
- Toward a new vaccine for pertussis (Q37628007) (← links)
- How to fight pertussis? (Q37668385) (← links)
- Is adolescent pertussis vaccination preferable to natural booster infections? (Q37960125) (← links)
- Adult vaccination in 11 Central European countries - calendars are not just for children (Q37973963) (← links)
- A critical literature review of health economic evaluations in pertussis booster vaccination (Q37978907) (← links)
- Shortened interval between tetanus vaccines (Q38016387) (← links)
- The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. (Q38043780) (← links)
- Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around.... (Q38068468) (← links)
- Strategies to control pertussis in infants (Q38108706) (← links)
- Adolescents and vaccines in the western world (Q38136802) (← links)
- Respiratory infections in the military (Q38151079) (← links)
- Vaccination of health care workers against pertussis: meeting the need for safety within hospitals (Q38159051) (← links)
- Epidemiology of whooping cough & typing of Bordetella pertussis (Q38160533) (← links)
- Vaccine responsiveness in the elderly: best practice for the clinic (Q38217108) (← links)
- Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines (Q38222258) (← links)
- Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology (Q38237077) (← links)
- Detection of Bordetella pertussis from Clinical Samples by Culture and End-Point PCR in Malaysian Patients (Q38284280) (← links)
- Seroprevalence studies of pertussis: what have we learned from different immunized populations (Q38553680) (← links)